melphalan
acrotech biopharma
outstanding presentation by on the first whole genome sequencing data from therapy-related myeloid tumors in myeloma patients, post high-dose melphalan followed by transplant. #ims2022 #mmsm #wgs 
Professor of Medicine, Chief of Myeloma Division & Experimental Therapeutics Program. Sylvester Comprehensive Cancer Center, University of Miami. Tweets = mine